Medical Imaging Reagents Market, By Product Type (Ultrasound Microbubble Agents, Contrast Reagents, Optical Imaging Dyes & Probes, Radiopharmaceuticals and Others), By Modality, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6328
|
Published Date
November 2026
|
Pages
289
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Medical Imaging Reagents market size was valued at US$ 13,608.7 Million in 2025, expanding at a CAGR of 5.5% from 2026 to 2033.
Medical imaging reagents refer to chemicals that are introduced into the body of the patient or the sample to enable visualization of various organs, tissues, blood vessels, and diseased areas through scanning. Some examples of medical imaging reagents include contrast agents, radionuclide tracers, and fluorescent dyes/probes for use in X-rays, CT and ultrasound, PET/SPECT nuclear imaging, and optical imaging, respectively. In the absence of medical imaging reagents, it would be very difficult for most scans to generate high-quality images of soft tissues and diseases at their early stages. This would make it almost impossible for doctors to identify any abnormalities within the patients\' body. The use of medical imaging reagents is critical in helping to improve the quality of the image generated for easy identification of diseases such as cancer, heart disease, and neurological diseases, among others.
Medical Imaging Reagents Market- Market Dynamics
Rising Burden of Chronic Diseases to propel market demand
The rising burden of chronic diseases is driving demand for medical imaging reagents, as they are useful in detecting, diagnosing, and monitoring chronic illnesses such as cancer, cardiovascular diseases, and neurological diseases. For instance, in January 2026, according to the Heart Health India Foundation Org., more than 60 percent of deaths in India are due to non-communicable diseases (NCDs). Furthermore, the report shows that cardiovascular disease accounts for 1 out of 4 deaths in the nation, with these deaths taking place a decade earlier than in high-income nations. There has been an increasing need for effective preventive measures and interventions. The increasing prevalence of chronic diseases is supporting the demand for advanced medical imaging reagents for accurate diagnosis and monitoring.
Medical Imaging Reagents Market- Segmentation Analysis:
The Global Medical Imaging Reagents market is segmented on the basis of Product Type, Modality, Application, End User, and Region.
Under product type, contrast reagents hold a significant share of the market. They are used in a huge number of applications of CT, MRI, X-ray, and ultrasound scanning, where iodinated products are used for most CT examinations, which makes them the key products in such applications. In April 2026, GE HealthCare revealed that the first patient has been dosed in the first international clinical trial of its contrast agent made up of manganese for MRI. The company is involved in manufacturing other contrast agents, including iodinated contrast media like Omnipaque and Visipaque, among other imaging agents, supporting the use of contrast reagents in medical imaging procedures and diagnostic applications.
Medical Imaging Reagents Market- Geographical Insights
North America will continue to play a significant role in the Medical Imaging Reagents market due to its well-developed medical imaging infrastructure and a high number of procedures carried out. The country will also benefit because of the presence of good reimbursement and development of imaging agents. For instance, in March 2026, according to the Fraser Institute Org., Canada stood 27th in the ranking among 31 countries regarding the availability of MRI machines per capita and 28th in terms of CT scanners per capita.
This suggests that there are shortcomings present in Canada\'s medical imaging infrastructure. Furthermore, more than a third of MRI and CT machines in Canada are more than 10 years old, which suggests that there is a strong need for equipment modernization. Moreover, 14% and 8% of MRI and CT scanners, respectively, are more than 15 years old, which makes it necessary to modernize the diagnostic imaging infrastructure. These infrastructure gaps and modernization needs are expected to support demand for advanced medical imaging reagents across North America.
Medical Imaging Reagents Market- Competitive Landscape:
The market consists of a few large imaging and pharmaceutical companies operating worldwide. The reason being the critical nature of safety, dosage, reliability, and proven clinical performance. Leading companies in the market are GE HealthCare, Bayer AG, Bracco Imaging S.p.A., Guerbet, and Lantheus Holdings. These companies supply the contrast agents and radiopharmaceuticals for diagnostic purposes to hospitals and medical imaging centers worldwide. In June 2026, Bayer received FDA approval for their low-dose MRI contrast agent, Ambelvist. The drug is now part of their lineup, which consists of Gadavist and Eovist. Innovation in the market will always be present as a result of the critical nature of safety, reliability, and accurate diagnostics. This is increasing competition within the market, and companies are looking to increase their portfolio of imaging reagents by innovation.
Recent Developments:
- In April 2026, GE HealthCare announced the first patient has been dosed in the Phase 2/3 LUMINA clinical trial of its investigational manganese-based MRI contrast agent mangaciclanol. It is being developed as a potential alternative to gadolinium-based contrast agents with the intention to improve MRI imaging and address concerns around gadolinium retention.
- In February 2026, Bracco announced FDA approval for a new indication for VUEWAY® (gadopiclenol) injection with use in neonates and infants. This new indication allows for their low-dose contrast agent to be used in younger patients for contrast-enhanced MRI, supporting contrast-enhanced MRI from birth through adulthood.
- In June 2025, Guerbet announced that Elucirem™ (gadopiclenol) has been approved by Australia\'s Therapeutic Goods Administration (TGA) for contrast-enhanced MRI. The macrocyclic gadolinium-based contrast agent is indicated for use in adults and children aged 2 years and above. It provides high relaxivity and effective imaging using less gadolinium.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICAL IMAGING REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GE HealthCare
- Bracco S.p.A.
- Lantheus Holdings, Inc.
- Siemens AG
- Bayer AG
- CMC Contrast AB
- Thermo Fisher Scientific Inc.
- Guerbet
- Telix Pharmaceuticals Limited
- Revvity, Inc.
- Novartis AG
- NorthStar Medical Radioisotopes, LLC
- SOFIE Biosciences
- PharmaLogic Holdings Corp.
- ITM Isotope Technologies Munich SE
- Jubilant Radiopharma
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Ultrasound Microbubble Agents
- Contrast Reagents
- Optical Imaging Dyes & Probes
- Radiopharmaceuticals
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- Hybrid Modalities (PET/CT, PET/MRI, SPECT/CT)
- X-ray & Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Imaging (SPECT & PET)
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Gastroenterology & Hepatology
- Cardiology & Vascular
- Musculoskeletal & Orthopedics
- Neurology
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Institutes
- Ambulatory Surgical Centers
- Hospitals
- Diagnostic Imaging Centers
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Medical Imaging Reagents Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Medical Imaging Reagents Market Snippet by Product Type
2.1.2. Medical Imaging Reagents Market Snippet by Modality
2.1.3. Medical Imaging Reagents Market Snippet by Application
2.1.4. Medical Imaging Reagents Market Snippet by End User
2.1.5. Medical Imaging Reagents Market Snippet by Country
2.1.6. Medical Imaging Reagents Market Snippet by Region
2.2. Competitive Insights
3. Medical Imaging Reagents Key Market Trends
3.1. Medical Imaging Reagents Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Medical Imaging Reagents Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Medical Imaging Reagents Market Opportunities
3.4. Medical Imaging Reagents Market Future Trends
4. Medical Imaging Reagents Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Medical Imaging Reagents Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Medical Imaging Reagents Market Landscape
6.1. Medical Imaging Reagents Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Medical Imaging Reagents Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Ultrasound Microbubble Agents
7.1.3. Contrast Reagents
7.1.4. Optical Imaging Dyes & Probes
7.1.5. Radiopharmaceuticals
7.1.6. Others
8. Medical Imaging Reagents Market – By Modality
8.1. Overview
8.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
8.1.2. Hybrid Modalities (PET/CT, PET/MRI, SPECT/CT)
8.1.3. X-ray & Computed Tomography (CT)
8.1.4. Magnetic Resonance Imaging (MRI)
8.1.5. Nuclear Imaging (SPECT & PET)
8.1.6. Others
9. Medical Imaging Reagents Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Oncology
9.1.3. Gastroenterology & Hepatology
9.1.4. Cardiology & Vascular
9.1.5. Musculoskeletal & Orthopedics
9.1.6. Neurology
9.1.7. Others
10. Medical Imaging Reagents Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Academic & Research Institutes
10.1.3. Ambulatory Surgical Centers
10.1.4. Hospitals
10.1.5. Diagnostic Imaging Centers
10.1.6. Others
11. Medical Imaging Reagents Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Medical Imaging Reagents Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Medical Imaging Reagents Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Medical Imaging Reagents Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Medical Imaging Reagents Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Medical Imaging Reagents Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Medical Imaging Reagents Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. GE HealthCare
12.2.2. Bracco S.p.A.
12.2.3. Lantheus Holdings, Inc.
12.2.4. Siemens AG
12.2.5. Bayer AG
12.2.6. CMC Contrast AB
12.2.7. Thermo Fisher Scientific Inc.
12.2.8. Guerbet
12.2.9. Telix Pharmaceuticals Limited
12.2.10. Revvity, Inc.
12.2.11. Novartis AG
12.2.12. NorthStar Medical Radioisotopes, LLC
12.2.13. SOFIE Biosciences
12.2.14. PharmaLogic Holdings Corp.
12.2.15. ITM Isotope Technologies Munich SE
12.2.16. Jubilant Radiopharma
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICAL IMAGING REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GE HealthCare
- Bracco S.p.A.
- Lantheus Holdings, Inc.
- Siemens AG
- Bayer AG
- CMC Contrast AB
- Thermo Fisher Scientific Inc.
- Guerbet
- Telix Pharmaceuticals Limited
- Revvity, Inc.
- Novartis AG
- NorthStar Medical Radioisotopes, LLC
- SOFIE Biosciences
- PharmaLogic Holdings Corp.
- ITM Isotope Technologies Munich SE
- Jubilant Radiopharma
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Ultrasound Microbubble Agents
- Contrast Reagents
- Optical Imaging Dyes & Probes
- Radiopharmaceuticals
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- Hybrid Modalities (PET/CT, PET/MRI, SPECT/CT)
- X-ray & Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Imaging (SPECT & PET)
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Gastroenterology & Hepatology
- Cardiology & Vascular
- Musculoskeletal & Orthopedics
- Neurology
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Institutes
- Ambulatory Surgical Centers
- Hospitals
- Diagnostic Imaging Centers
- Others
GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
